Search PubMed⌕ Search

Biomedical subjects

J Minowada

Publications and source records attributed to J Minowada.

At least 253 records · Page 14Linked to original sources
PubMed1979

Cultured human leukemic non-T/non-B lymphoblasts and their stimulating capacity in "one-way" mixed lymphocyte reaction: suggestive evidence for early T-cell or B-cell precursors.

It is now well recognized that a large proportion of cases with acute lymphoblastic leukemia are classified as non-T/non-B neoplastic disease. The origin of leukemic non-T/non-B cells is at present not known. It has been shown that fresh or cultured leukemic T lymphoblasts exert no stimulating capacity while leukemic B lymphoblasts exert a strong stimulation in "one-way" mixed lymphocyte reaction. It has also been shown that fresh leukemic cells from some patients with non-T/non-B acute lymphoblastic leukemia possess a strong stimulation while leukemic cells from other patients with this disease possess no stimulation on allogeneic lymphocytes. The present study shows that cultured leukemic lymphoblasts from 3 non-T/non-B cell lines (NALL-1, NALM-6 and NALM-16) consistently exert a strong stimulation on allogeneic lymphocytes. On the other hand, cultured leukemic lymphoblasts from 2 non-T/non-B cell lines (REH and KM-3) consistently fail to stimulate in "one-way" mixed lymphocyte reaction. Our data clearly support the speculation that leukemic non-T/non-B cells which possess the stimulating capacity may represent less differentiated leukemic B lymphoid cells (pre-B cells) and leukemic non-T/non-B cells which possess no stimulating capacity may represent less differentiated leukemic T lymphoid cells (per-T cells).

Animals↗
PubMed1979

T-cell chronic lymphocytic leukemia: report of a case and review of the literature.

We recently observed a unique case of T-cell type chronic lymphocytic leukemia, documented by cell surface marker analyses. Immunologic tests at the time of diagnosis were as follows: 1) skin tests were negative; 2) in vitro lymphocyte responses to antigens or pokeweed mitogen were absent; 3) in vitro lymphocyte responses to phytohemagglutinin, concanavalin-A or allogeneic cells were low but significant; and 4) stimulating capacity of leukemic T cells were absent. Chromosomal analysis of bone marrow showed a pattern of 45 chromosomes with a marker chromosome. Terminal deoxynucleotidyl transferase activity was very low. Patient responded extremely well to COP (cyclophosphamide-oncovin-prednisone) therapy. Patient died of recurrent transitional cell carcinoma while his leukemia was in complete remission, approximately 20 months after the diagnosis of T-cell CLL.

Aged↗
PubMed1979

Chromosomes and causation of human cancer and leukemia. XXXIII. 5q-- in a case of acute lymphoblastic leukemia (ALL).

The case of a 4-year-old boy with ALL, possibly developing subsequent to a lymphoma involving the thoracic cavity, which was shown to be of the T-cell type, is presented. The leukemic cells had a 5q-- anomaly, which had previously been described only in cases of refractory anemia and/or AML. The 5q-- abnormality was invariably accompanied by a 9p-- chromosome in the leukemic cells. The interstitial deletion leading to the 5q-- chromosome was shown with banding techniques to be similar to that described previously in myeloproliferative disorders. Some aspects of the 5q-- anomaly in ALL and its relation to previous experience with this karyotypic change are discussed.

Antigens↗
PubMed1979

Quantitation of human thymus-leukemia-associated antigen in established hematopoietic cell lines by radioimmunoassay.

A competitive radioimmunoassay for a saline-soluble human thymus-leukemia-associated antigen (HThy-L) was applied for quantitation of this antigen in leukemia and normal hematopoietic cell lines. Highly increased quantities of HThy-L were detected in all T-cell leukemia lines tested, regardless of the presence or absence of receptors for sheep erythrocytes. This elevated level of HThy-L in combination with high terminal deoxynucleotidyl transferase and adenosine deaminase activities and the presence of a T-lymphocyte-specific surface antigen appear to represent stable phenotypic characteristics of T-cell lines. Most normal B-cell lines had low quantities of HTy-L. The level of HThy-L was slightly elevated in a considerable number of lymphoma B-cell lines and in all non-T, non-B leukemia cell lines tested. No relationship existed between quantities of HThy-L and an expression of different surface immunoglobulin isotypes in B-cell lines. Low quantities of HThy-L were detected in leukemia myeloid and myeloma cell lines as well as in B-cell leukemia lines originating from patients with B-cells acute lymphoblastic leukemia. Apparently, the increased quantities of HThy-L in T-cell leukemia lines may be related to certain stages of T-cell differentiation at which leukemia cell transformation occurs.

Antigens, Neoplasm↗
PubMed1979

Differential response of sister chromatid exchange and chromosome aberrations to mitomycin C of normal and abnormal human lymphocytic cell lines.

Mitomycin C (MMC) induced chromosome aberrations and an increased sister chromatid exchange (SCE) incidence in a cell line derived from normal lymphocytes, whereas in lines originating from cells of chronic lymphocytic leukemia (lines SN1029 and SN1033) and Burkitt lymphoma (lines B35 M and HR1K) MMC caused a striking increase in SCE, but not in the frequency of chromosome abnormalities. The latter may be due to the failure of the cells with chromosome aberrations to survive, possibly related to their high sensitivity to MMC. The increased rate of SCE with MMC treatment was more marked in the neoplastic lymphocytic cells than in the normal ones; the sensitivity of SN1029 and SN1033 cells was 10 times higher and that of B35M and HR1K cells about 5 times higher than that of the normal cells. These observations suggest that the MMC-induced high rate of SCE in the neoplastic cells may in some aspects differ from the mechanism(s) leading to chromosome aberrations; and that SCE is a much more sensitive indicator of MMC effects than chromosome aberrations.

Animals↗
PubMed1979

Human myeloma cells and their strong stimulating capacity in 'one-way' mixed lymphocyte reaction: a comparative study with leukaemic B lymphoid cells.

Cultured human myeloma cells (ARH-77, RPMI-8226 and U-266), like leukaemic B lymphoid cells, consistently exerted a strong stimulating capacity on allogeneic lymphocytes in the 'one-way' mixed lymphocyte reaction. An optimal stimulation was seen when a 1:1 ratio or 1:2 ratio of responding cell:stimulating cells of each cell line was utilized. The stimulating capacity of ARH-77 or RPMI-8226 cells was significantly diminished when a 1:4 ratio of responding cells:stimulating cells was utilized. Fresh bone marrow cells containing more than 80% plasma cells from a patient with multiple myeloma, on the other hand, failed to exert the stimulating capacity on two occasions. The striking difference between cultured myeloma cells and fresh plasma cells is that the Ia-like antigen is present on cultured myeloma cells, and this antigen is absent on fresh plasma cells. The relationship between the Ia-like antigen and the stimulating capacity in 'one-way' mixed lymphocyte reaction is discussed.

Antigens, Neoplasm↗
PubMed1979

Induction, inhibition, and biological properties of aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788.

Aryl hydrocarbon hydroxylase was induced in the absence of mitogens by several compounds in a stable, human B-lymphocyte cell line (RPMI-1788). Over the dose ranges tested and on molar basis the inducers, in decreasing order of potency, were 2,3,7,8-tetrachlorodibenzo-p-dioxin, dibenz(a,h)-anthracene, 3-methylcholanthrene, benzo(a)pyrene, and 1,2-benzanthracene. Potential inducers which, paradoxically, diminished basal aryl hydrocarbon hydroxylase, included 7,12-dimethylbenzanthracene, 2,5-diphenyloxazole, and chyrsene. Induction under optimal culture conditions ensured maximal activities 3- to 4 fold above basal aryl hydrocarbon hydroxylase. The characteristics of the induced [dibenz(a,h)anthracene] and basal enzymes were found virtually identical. Both had similar pH curves (optima at 8.25) and inhibitor specificity (alpha- and beta-naphthoflavones, metyrapone, and 2-diethylaminoethyl-2,2-diphenylvalerate in decreasing potency). Induced and basal enzymes exhibited similar half-lives (41, 46 hr), apparent activation energies (16.7, 16.6 kcal/mol), temperature optima (37-38, 38-39 degrees), temperature-dependence of denaturation (range, 42-50 degrees), and apparent Km's with benzo(a)pyrene (1.8, 0.8 microM). The small difference in the apparent Km was related to enzyme concentration in the incubation rather than to the quality of the enzyme.

Aryl Hydrocarbon Hydroxylases↗
PubMed1979

Human thymus cells: a study of rosette-forming capacity with unsensitized and sensitized erythrocytes of various species.

Human thymus cells from 117 donors aged 2 months to 15 years, were studied for rosette-forming capacity with unsensitized and sensitized erythrocytes of various species. Viability of the thymus cells at the completion of isolation ranged from 95 to 99%. Over 90% of the total population of thymus cells were identified as T lymphocytes by either standard Es-rosette assay utilizing a 4 degree incubation with preceding centrifugation or T--LCL assay, on the average. Gravity Es-rosette assay high affinity Es-rosette assay, stable Es-rosette assay or active Es-rosette assay for identification of subsets of T lymphocytes indicate that most of the human thymus cells were capable of forming rosettes with unsensitized sheep erythrocytes at higher degrees of temperature with or without preceding centrifugation. Approximately half of the human thymus cells were also capable of forming rosettes with unsensitized allogeneic erythrocytes. Less than 3% of the thymus cells expressed receptors for the Fc portion of IgG (T gamma suppressor cells) whereas less than 1% of thymus cells expressed receptors for the Fc portion of IgM (T mu helper cells), indicating that most of the thymus cells are non-T mu/non T gamma cells. Only 1% or less of the thymus cells were identified as B cells by the SIg assay, the Em-rosette assay or the Ia-like antigen assay. There was no significant difference of any rosette assay between males and females or among various age groups.

Adolescent↗
PubMed1979

Human T and B lymphoid cells: an electron microscopic study on thymocytes, peripheral blood lymphocytes, mitogen-stimulated cells and lymphoid cell lines.

Human lymphoid cells were studied by electron microscopy to find any morphological difference between T and B cells. The T cell population generally contains a smaller amount of the rough endoplasmic reticulum than the B cell in various functional states, i.e. peripheral blood lymphocytes of normal individuals, mitogen-stimulated lymphoblasts and lymphoid cell lines. This may depend on greater need of the rough endoplasmic reticulum for immunoglobulin synthesis in B cells, even though T cells produced some soluble mediators. Other differences between T and B cells are as follows: (1) Peripheral blood T lymphocytes often have clustered dense granules, while granules containing parallel tubular structures are more frequently seen in B lymphocytes. (2) Cultured T cell lines usually exhibit a higher nuclear-cytoplasmic ratio and less prominent nucleoli than B cell lines.

B-Lymphocytes↗
PubMed1979

Human cell membrane components dominant in T cell lineage: identification and characterization of human TL-like antigens.

Cell membrane components that contain beta 2-microglobulin were purified from cells of a human T cell-type leukemia cell line, HPB-ALL. They contained membrane components that have the same molecular size and the same subunit structure as HLA(A,B,C) antigens but are separable from the typical beta 2-microglobulin-containing cell membrane components, i.e., the HLA (A,B,C) antigens, by xenoantibody reagents. A sensitive radioimmunoassay was constructed for detection of the T cell membrane components. The assay revealed that the cell membrane components are expressed exclusively on cells of T cell-type leukemia cell lines among the human lymphoid cell lines tested, predominantly in thymus, among the human organs and tissues tested. They were not present on cells of human B cell-type cell lines or on cells of nonlymphoid organs and tissues. No alloantibodies directed to the T cell membrane components, the putative human homologues of mouse TL antigens, were found in any of the human tissue typing sera tested.

Animals↗
PubMed1978

Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer.

To test whether the distribution of AHH inducibility is shifted toward the high end of the range in patients who had lung and laryngeal cancer, we measured this trait in 59 patients (32 lung and 27 laryngeal) who had resectable tumors and had been disease-free for a period of time. The advantage of selecting patients who were free of clinical disease was that measurement of their AHH inducibility should not have been affected by the disease state. Patient and control populations showed no difference in basal and induced AHH activity of AHH inducibility. The mean AHH inducibility in patients who had lung cancer was 3.20 +/- 0.20; in patients who had laryngeal cancer 2.96 +/- 0.18, and for all controls 3.29 +/- 0.04 (no significant difference at p = 0 05). Further analysis of the distribution of AHH inducibility in the patient group compared to controls showed no suggestion of a shift toward the higher end of the range in patients who had lung and laryngeal cancer.

Adenocarcinoma↗